If proton pump inhibitors fail to control the symptoms of gastro-oesophageal reflux disease, current standard management is to double the drug dose, despite limited therapeutic gain.

    • Please note: The rest of this article is only available to subscribers of the Journal of Chinese medicine. Please subscribe now.

Categories: Digestive & Bowel disorders

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now